For the divisions, We expect Concorde will be at or slightly above the high end of the previous expected revenue range of $170,000,000 to $175,000,000 And we continue to expect low single digit revenue growth for UTI. We are raising our adjusted EBITDA expectations from the prior range of 58,000,000 $62,000,000 to a new range of $62,000,000 to $64,000,000 For adjusted net income, we are raising the prior range of $14,000,000 to 18,000,000 to a new range of $17,000,000 to $20,000,000 And for adjusted free cash flow, we are raising the range to $44,000,000 to $46,000,000 versus the prior range of $40,000,000 to $45,000,000 Alongside the updated financial expectations, we are reiterating Our previously disclosed fiscal 2023 total new student start guidance with an expected range of between 22,023,500. As Jerome mentioned earlier, our total starts are currently tracking towards the middle of this range. For the Concorde division, we expect starts at or slightly above the upper end of their 7,500 to 8,000 range. For the UTI division, we continue to anticipate starts Be at the low end of their 14,500 to 15,500 range, which represents approximately 8% year over year growth.